Gates Foundation awards MassBiologics $2M to develop treatment for enteric diarrhea.
Serum Institute of India launches Rabishield, in partership with MassBiologics.
MassBiologics developing promising alternative treatment for diphtheria.
MassBiologics Discovery granted FDA approval.
MassBiologics and AbCellera partner to discover fully human antibodies against drug-resistant bacteria.
MassBiologics collaborator AbCellera Announces their Success.
Grifols Obtains Exclusive Rights to Market and Distribute MassBiologics' Td Vaccine in US.
Voyager Therapeutics and MassBiologics Announce Strategic Collaboration for Viral Vector Manufacturing
MassBiologics CEO, Mark Klempner discusses Lyme disease